TP-271
TP-271 is a compound with the potential to inhibit community-acquired pneumonia.
Product Specifications
CAS Number
[1207284-17-0]
UNSPSC
12352005
Target
Bacterial
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-immunoregulation
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/tp-271.html
Smiles
O[C@]12[C@](C[C@@]3([H])C(C(C4=C(O)C(NC([C@H]5N(CCC5)C)=O)=CC(F)=C4C3)=O)=C2O)([H])[C@@H](C(O)=C(C1=O)C(N)=O)N(C)C
Molecular Formula
C27H31FN4O8
Molecular Weight
558.56
References & Citations
[1]Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1022556-01 0.02 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0644 (AF_0644)
Ask
View Details 
MBS1022556-02 0.1 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0644 (AF_0644)
Ask
View Details 
MBS1022556-03 0.02 mg (Yeast)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0644 (AF_0644)
Ask
View Details 
MBS1022556-04 0.1 mg (Yeast)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0644 (AF_0644)
Ask
View Details MBS1022556-05 0.02 mg (Baculovirus)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0644 (AF_0644)
Ask
View Details MBS1022556-06 1 mg (E-Coli)
Recombinant Archaeoglobus fulgidus Uncharacterized protein AF_0644 (AF_0644)
Ask
View Details